{"id":"https://openalex.org/W33156971","doi":null,"title":"Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experience.","display_name":"Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experience.","alternate_titles":[],"publication_year":2003,"publication_date":"2003-05-01","ids":{"openalex":"https://openalex.org/W33156971","mag":"33156971","pmid":"https://pubmed.ncbi.nlm.nih.gov/12744301"},"language":"en","primary_location":{"id":"pmid:12744301","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12744301","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of managed care","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W33156971"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082618238","display_name":"Darren M. Kocs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]},{"id":"https://openalex.org/I4210114445","display_name":"Michigan Medicine","ror":"https://ror.org/01zcpa714","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Darren Kocs","raw_affiliation_strings":["Divisions of Hematology/Oncology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109-0429, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Divisions of Hematology/Oncology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109-0429, USA","institution_ids":["https://openalex.org/I27837315","https://openalex.org/I4210114445"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087546386","display_name":"A. Mark Fendrick","orcid":"https://orcid.org/0000-0002-7734-6742","observed_orcids":["https://orcid.org/0000-0002-7734-6742"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Mark Fendrick","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.8137,"has_fulltext":false,"cited_by_count":47,"citation_normalized_percentile":{"value":0.87277241,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"9","issue":"5","first_page":"393","last_page":"402"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9101999998092651,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9101999998092651,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.027400000020861626,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.022099999710917473,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/off-label-drug-use","display_name":"off-label drug use","score":0.996999979019165},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9959999918937683},{"id":"https://openalex.org/keywords/drug-costs","display_name":"drug costs","score":0.824999988079071},{"id":"https://openalex.org/keywords/drug-utilization-patterns","display_name":"drug utilization patterns","score":0.7080000042915344},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.6019999980926514}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.910697340965271},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.7574455142021179},{"id":"https://openalex.org/C188313352","wikidata":"https://www.wikidata.org/wiki/Q119697","display_name":"Off-label use","level":2,"score":0.742758572101593},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.6786327362060547},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5625585913658142},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5481016635894775},{"id":"https://openalex.org/C27415008","wikidata":"https://www.wikidata.org/wiki/Q7256382","display_name":"Psychological intervention","level":2,"score":0.46620333194732666},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.45500561594963074},{"id":"https://openalex.org/C129930760","wikidata":"https://www.wikidata.org/wiki/Q1702613","display_name":"Pharmaceutical care","level":3,"score":0.453936904668808},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3545758128166199},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.28005996346473694},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.25907859206199646},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.16636860370635986},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.09694969654083252}],"mesh":[{"descriptor_ui":"D000046","descriptor_name":"Academic Medical Centers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002173","descriptor_name":"Cancer Care Facilities","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004348","descriptor_name":"Drug Labeling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004513","descriptor_name":"Education, Pharmacy, Continuing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006302","descriptor_name":"Health Services Research","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017721","descriptor_name":"Hospital Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017723","descriptor_name":"Drug Utilization Review","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:12744301","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12744301","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of managed care","raw_type":"Journal Article"},{"id":"mag:33156971","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12744301","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W1488534937","https://openalex.org/W1521212721","https://openalex.org/W1888052455","https://openalex.org/W1960963378","https://openalex.org/W1972854894","https://openalex.org/W1974840411","https://openalex.org/W1984317600","https://openalex.org/W2014094159","https://openalex.org/W2028765462","https://openalex.org/W2032581026","https://openalex.org/W2039816037","https://openalex.org/W2042443102","https://openalex.org/W2102443735","https://openalex.org/W2103659724","https://openalex.org/W2110040506","https://openalex.org/W2119281473","https://openalex.org/W2134310663","https://openalex.org/W2145576756","https://openalex.org/W2157814185","https://openalex.org/W2158003437","https://openalex.org/W2170658684","https://openalex.org/W2286609730","https://openalex.org/W2360731129","https://openalex.org/W2508002109","https://openalex.org/W2551526093","https://openalex.org/W2606560112","https://openalex.org/W2765441275","https://openalex.org/W2798262146","https://openalex.org/W2799739577","https://openalex.org/W2888185006","https://openalex.org/W2944824315","https://openalex.org/W3093778256","https://openalex.org/W3122536954","https://openalex.org/W4214532600","https://openalex.org/W4250146877","https://openalex.org/W4298177353"],"related_works":["https://openalex.org/W2116956631","https://openalex.org/W2477738642","https://openalex.org/W3188044829","https://openalex.org/W2118167058","https://openalex.org/W2974593603","https://openalex.org/W2619536322","https://openalex.org/W2585653680","https://openalex.org/W3148007573","https://openalex.org/W2101116893","https://openalex.org/W2402914620"],"abstract_inverted_index":{"BACKGROUND:":[0],"While":[1],"the":[2,10,16,31,82,101,124,131,138,215],"off-label":[3,13,71,94,104,135,141,151,177,185,197,218],"use":[4,14,95,105,144,178,198],"of":[5,63,96,103,119,130,140,184,191,199,204,207],"oncology":[6,20,108,192],"interventions":[7],"is":[8,201],"widespread,":[9],"factors":[11,91,167],"influencing":[12],"and":[15,49,60,99,142,187,209],"resultant":[17,78],"influence":[18,93,175],"on":[19,106,176],"drug":[21,109,193,210],"expenditures":[22,211],"are":[23],"not":[24],"well":[25],"understood.":[26],"STUDY":[27],"DESIGN:":[28],"To":[29],"assess":[30],"indications":[32],"for":[33,84,134,214,217],"rituximab":[34,64,121,200],"use,":[35],"a":[36,42,85,117,147,173],"retrospective":[37],"review":[38],"was":[39,65],"undertaken":[40],"at":[41,146],"single":[43],"academic":[44],"center":[45],"between":[46],"September":[47],"1998":[48],"June":[50],"2001.":[51],"METHODS:":[52],"Patient":[53],"diagnoses":[54],"were":[55,81,133],"linked":[56],"to":[57,89],"pharmacy":[58],"records,":[59],"each":[61],"administration":[62],"classified":[66],"as":[67,72,158],"either":[68],"on-label":[69,143,159],"or":[70,171],"defined":[73],"by":[74],"FDA-approved":[75],"indications.":[76,136],"The":[77,196],"utilization":[79,152,186],"patterns":[80,183,206],"foundation":[83],"conceptual":[86,163],"model":[87,164],"designed":[88],"identify":[90],"that":[92,165,168],"oncology-related":[97,205],"therapeutics":[98],"forecast":[100],"effect":[102],"aggregate":[107],"expenditures.":[110,194],"RESULTS:":[111],"One":[112],"hundred":[113],"one":[114],"patients":[115],"received":[116],"total":[118],"428":[120],"administrations":[122,132],"during":[123],"study":[125],"period.":[126],"Most":[127],"(320,":[128],"75%)":[129],"Although":[137],"extent":[139],"grew":[145],"similar":[148],"rate":[149],"initially,":[150],"increased":[153],"nearly":[154],"exponentially":[155],"over":[156],"time":[157],"uses":[160],"lessened.":[161],"A":[162],"describes":[166],"promote,":[169],"inhibit,":[170],"have":[172],"mixed":[174],"may":[179],"help":[180],"predict":[181],"future":[182],"allow":[188],"better":[189],"forecasting":[190],"CONCLUSIONS:":[195],"substantial.":[202],"Projections":[203],"care":[208],"must":[212],"account":[213],"potential":[216],"use.":[219]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W33156971","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2016-06-24T00:00:00"}
